Intrinsiqq

Vistin Pharma ASA (VISTN.XOSL) Dividend Analysis

Does Vistin Pharma ASA (VISTN.XOSL) pay a dividend?

Yes. Vistin Pharma ASA (VISTN.XOSL) pays a dividend: NOK 1.00 per share over the last twelve months, a dividend yield of 5.63% at the latest close.

Its dividend per share has shrunk at 10.6% a year over the last 2 years. The payout takes about 59.3% of earnings.

Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Dividend per share by fiscal year
Fiscal yearPer shareChange
2025NOK 1.00-42.9%
2024NOK 1.75+40.0%
2023NOK 1.25
2020NOK 0.50-50.0%
2019NOK 1.00

All 5 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.

VISTN.XOSL
Dividend32
High yield, verify sustainability

Earnings payout ratio is moderate, no sustained growth pattern yet.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

18

Safety

40% of composite

Earnings Payout0
N/ANot reported
FCF Coverage35
1.4xThin margin
0

Growth

35% of composite

Dividend Streak0
0YNo sustained streak
Growth Rate0
-10.6%Declining
100

Income

25% of composite

Cash Yield (TTM)100
5.63%High, verify safety

Composite = Safety (18) × 0.40 + Growth (0) × 0.35 + Income (100) × 0.25 = 32

Dividend Yield

5.63%

Per Share (TTM)

NOK 1.00

Payout Ratio

59.3%

2Y CAGR

-10.6%

Dividend Safety

Earnings Payout

59.3%

FCF Payout

72.3%

FCF Coverage

1.4x

Dividend Growth

Per Share (TTM)

NOK 1.00

Growth Streak

—

2Y CAGR

-10.6%

Dividend Income

Annual DPS (TTM)

NOK 1.00

Annual Income / €10K

€563

Payment frequency, ex-dividend and payment dates are not available from company filings. Check your broker or the company's investor relations page for the schedule.

Yield History

Vistin Pharma ASA (VISTN.XOSL) dividend: yield, safety and growth

Frequently asked

Does Vistin Pharma ASA (VISTN.XOSL) pay a dividend, and how much?+

Yes, Vistin Pharma ASA pays a regular dividend of about NOK 1.00 per share per year (a yield of roughly 5.6%). That is a payout ratio of about 59.3% of earnings, so it is covered by free cash flow. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.

Is Vistin Pharma ASA's dividend safe?+

Vistin Pharma ASA's dividend looks covered by free cash flow, with free cash flow covering the payout about 1.4 times over. Intrinsiqq scores its dividend safety at 58 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.

Has Vistin Pharma ASA grown its dividend?+

Vistin Pharma ASA's dividend history is mixed. Recent dividend growth has been roughly flat. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.

What is Vistin Pharma ASA's dividend payout ratio?+

Vistin Pharma ASA pays out about 59.3% of its earnings as dividends. A lower payout ratio leaves more room to keep raising the dividend and to absorb a bad year, while a very high ratio can signal a payout under pressure. On this measure the dividend is covered by free cash flow. See the dividend-safety breakdown for the free-cash-flow view, which is often more telling than earnings.

More on VISTN.XOSL: Overview · Quality scorecard · DCF valuation · Financials

Related stocks: Drug Manufacturers - Specialty & Generic

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.